What Happened?
Carlsbad, CA-based Signal Genetics has Appointed Sudipto Sur as Chief Information Officer
About the Company
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.
About the Person
Sudipto Sur is a seasoned technology leader and engineer. As CTO, he will apply his extensive experience developing pioneering solutions in robotics, vision systems, analytics, medical devices, and diagnostics to advance Reflexion Health’s technology platform. He will also serve as a member of Reflexion Health’s executive leadership team where he will help drive the company’s vision while enhancing Reflexion Health’s engineering and digital capabilities as well as its IT infrastructure. Sur brings more than 20 years of engineering, technology development and management experience to the Reflexion Health team. Most recently, he served as chief information officer at Signal Genetics, Inc., a commercial-stage molecular diagnostics company, where he developed an IT infrastructure for cloud-based clinical analytics and billing systems. Prior to Signal, Dr. Sur was founder and CEO of two companies: Anssur Corp, an engineering and software services provider for analytics and medical robotics, and Miralex Systems Inc., where he led the development of next-generation human computer interface platforms. He also served as director of research and development at Sequenom. Dr. Sur received his Ph.D. and M.S. in control systems and robotics from the California Institute of Technology. He received his B.S. in mechanical engineering from the Indian Institute of Technology in Mumbai, India.
Info Source
News
Short Profile